𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal Growth Factor Receptor Inhibitors in the Treatment of Nonmelanoma Skin Cancers

✍ Scribed by MISBAH H. KHAN; MURAD ALAM; SIMON YOO

Book ID
109078279
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
488 KB
Volume
37
Category
Article
ISSN
1076-0512

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical implications of the mechanism o
Clinical implications of the mechanism of epidermal growth factor receptor inhibitors
✍ John Marshall πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 189 KB πŸ‘ 2 views

## Abstract Novel therapeutic agents that target the epidermal growth factor receptor (EGFR) constitute an important addition to the therapeutic armamentarium for the treatment of metastatic disease. EGFR‐targeted agents currently approved by the U.S. Food and Drug Administration include cetuximab,

Somatic mutations of epidermal growth fa
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
✍ Hisayuki Shigematsu; Adi F. Gazdar πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 540 KB

Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene in lung cancers have generated enormous interest, because they predict for sensitivity to TK inhibitors (TKIs). While mutational status is of great importance in determining response to TKIs, it